Medline (MDLN) Net Income towards Common Stockholders (2025 - 2026)
Medline's (MDLN) quarterly Net Income towards Common Stockholders came in at $239.0 million in Q1 2026, down 25.78% year-on-year from $322.0 million in Q1 2025, and down 25.78% on a QoQ basis from $322.0 million in Q1 2025.
Medline (MDLN) Net Income towards Common Stockholders (2025 - 2026) Analysis & Trends
Medline (MDLN) has 2 years of Net Income towards Common Stockholders data on file, last reported at $239.0 million in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 25.78% year-over-year to $239.0 million in Q1 2026; TTM through Mar 2026 was $561.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 3.58% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $239.0 million, down from $322.0 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for MDLN reached as high as $322.0 million in Q1 2025 and fell as low as $239.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.79 Bn | 121.57 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 45.00 Bn | 44.18 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.87 Bn | 30.63 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.50 Bn | 27.84 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.14 Bn | 22.71 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.88 Bn | 13.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.15 Bn | 11.09 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Baxter International | 11.97 Bn | 9.95 Bn | 891.00 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 239.00 Mn |
| Mar 29, 2025 | 322.00 Mn |